We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Advanced Particle Beam Treatment Center to Provide Advanced Radiotherapy

By HospiMedica staff writers
Posted on 01 Aug 2007
A new particle-therapy center is expected to be the first of its kind in the United States to provide the state-of-the-art radiotherapy to cancer patients.

Touro University (Mare Island, CA, USA) president Bernard Lander announced that particle beam therapy for cancer, including proton beam and heavy carbon ions, is expected to be offered at the school's future US$1.2 billion health science research campus on Mare Island in Northern California, USA. More...
Currently, combined particle therapy is available only in Japan and Germany.

Touro plans to develop a Particle Therapy Center as part of this overall investment. Touro will be using integrated software systems and advanced equipment from Siemens Medical Solutions (Erlangen, Germany).

"This Center will be an important contribution to radiotherapy of cancer in the United States,” said Dr. Lander. The planned facility, which is expected to be the first of its kind west of the state of Mississippi in the United States, will utilize Siemens' latest technology. Siemens and Touro have signed a contract for project development, and are finalizing the design and moving forward.

The Center is being developed under an agreement between Touro University and the City of Vallejo, CA, USA, whereby the University will anchor a larger master planned University Village and Health Science Research Campus. At present, Touro University has four colleges on Mare Island, emphasizing broad aspects of health education and medicine on a 44-acre campus.

"The new center is expected to be a world-class facility with the latest green building designs and sustainable technology in the heart of a bio-tech industry that advances the future of medicine,” said Bruce Lang, West Coast land resources business practice manager for ARCADIS, the project's development manager.

Siemens is pleased to be collaborating with Touro University in the fight against cancer in this country. The particle therapy solution proposed is subject to final FDA [U.S. Food and Drug Administration] clearance upon completion. Siemens has made a major investment in particle therapy research and development and looks forward to working on this project in the Bay area,” said Dennis Falkenstein, vice president of particle therapy solutions at Siemens Medical Solutions.

Touro University is educating more than 1,400 students at colleges of osteopathic medicine, pharmacy, health sciences and education.


Related Links:
Touro University
Siemens Medical Solutions

Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Sling
GoComfort
New
Hospital Stretcher
Millennium 5
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.